Currently Viewing:
Currently Reading
Home Monitoring Device for Blood Cell, Neutrophil Counts Shows Positive Initial Results
February 21, 2019 – Jaime Rosenberg
What We're Reading: Importing Insulin; Teen Depression and Anxiety; Gene Editing Guidelines
February 21, 2019 – AJMC Staff
FDA Clears Phone App for d-Nav Insulin Guidance Service
February 20, 2019 – Mary Caffrey
Aging Population Continuing to Drive National Health Spending, Report Says
February 20, 2019 – Allison Inserro
Once-Weekly Carfilzomib Safe, Effective in All Age Groups of Patients With RRMM
February 20, 2019 – Laura Joszt
What We're Reading: Young Blood Injections; Gilead Accused of Kickbacks; Minor Consent for PrEP
February 20, 2019 – AJMC Staff
Real-World Study Finds Better Outcomes in MS After Early Intensive Therapy
February 20, 2019 – Samantha DiGrande
Pursuing Eradication of Cervical Cancer Through Preventive Interventions
February 20, 2019 – Wallace Stephens
Patients With MS Face Substantial, but Differing, Burdens in Japan, EU, and US
February 19, 2019 – Laura Joszt

What We're Reading: CMS May Require Medicare Hospitals Follow New Antibiotic Controls

AJMC Staff
What we're reading, June 14, 2016: CMS has proposed requiring Medicare hospitals follow new antibiotic controls; New York poised to expand access to breast cancer screening; and clinical trials are seeing more success.
CMS has proposed that Medicare hospitals closely manage the use of antibiotics or be ejected from the program. According to The Wall Street Journal, CMS would require that hospitals adopt new antibiotic controls in an attempt to reduce overuse. Federal health officials are concerned about the growing threat of antibiotic resistant bacteria. Under the proposal, hospitals would have someone in charge of antibiotic oversight.

New York is looking to increase access to breast cancer screening under a new deal by lawmakers. Hospitals would be required to expand hours when mammograms are offered and insurers would have to eliminate deductibles and copays for some diagnostic tests, including screening, reported the AP. The measure is expected to pass with the support of Governor Andrew Cuomo, the Democratic assembly speaker, and the Republican senate leader.

Clinical trials are reporting greater success rates. STAT reported that more than 11% of clinical trials succeeded between 2012 and 2014, which reversed the downward trend of the last 2 decades. The declines in clinical trial success rates was attributed to many drug makers cutting back on R&D. The success rate had bottomed out at 7.5% between 2008 and 2011, which was far below the 16.4% success rate seen between 1996 and 1999.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!